In Vitro Effects of Permethrin on Sinonasal Epithelia

By rosaguerrero • July 22, 2022

Lee JT, Yang HH, Sanghoon Shin D, Srivatsan E, Basak S. In Vitro Effects of Permethrin on Sinonasal Epithelia. OTO Open. 2022 Jul 14;6(3):2473974X221109838. doi: 10.1177/2473974X221109838. PMID: 35860617; PMCID: PMC9289904.

Tags: chemicals, chronic rhinosinusitis, epithelial cell, Hematology/Oncology, pesticide, Publications, toxicant

Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab, in combination with chemotherapy, in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11, KEAP1, or KRAS: the TRITON study

Skoulidis F, Borghaei H, Garon EB, Leal TA, Kaufman J, Liu SV, Nadler E, Patel SP, Peters S, Ricciuti B, Gautam A, Emeribe U, Luciani-Silverman[...]

Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical Trial

Agrawal R, Weiner AB, Livingstone J, Pooli A, Huang RR, Ye H, Sisk A, Elashoff DA, Boutros PC, Rettig MB, Reiter RE. Neoadjuvant Antiandrogen Therapy[...]

Safety and Clinical Outcomes of Pembrolizumab Standard-Interval Dosing Versus Extended-Interval Dosing in Patients with Breast Cancer

LeVee A, Kordic A, Ruel N, Mortimer J, Kang I, McArthur H, Lechner MG, Tsai K. Safety and Clinical Outcomes of Pembrolizumab Standard-Interval Dosing Versus[...]